Augmedix Inc
NASDAQ:AUGX
Augmedix Inc
NASDAQ:AUGX
Price:
2.71 USD
1.88%
Market Closed
Updated:
May 5, 2024
Augmedix Inc
Selling, General & Administrative
|
Augmedix Inc
Selling, General & Administrative Peer Comparison
Comparables:
VEEV
INSP
EVH
DOCS
CERT
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Augmedix Inc
NASDAQ:AUGX
|
Selling, General & Administrative
-$29.1m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Selling, General & Administrative
-$628m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-26%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Selling, General & Administrative
-$452m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
N/A
|
|
|
Evolent Health Inc
NYSE:EVH
|
Selling, General & Administrative
-$306.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Selling, General & Administrative
-$159.5m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Certara Inc
NASDAQ:CERT
|
Selling, General & Administrative
-$127.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
See Also
What is Augmedix Inc's Selling, General & Administrative?
Selling, General & Administrative
-29.1m
USD
-29.1m
USD
Based on the financial report for Dec 31, 2023, Augmedix Inc's Selling, General & Administrative amounts to -29.1m USD.
What is Augmedix Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-12%
-12%
Over the last year, the Selling, General & Administrative growth was -11%. The average annual Selling, General & Administrative growth rates for Augmedix Inc have been -22% over the past three years , -12% over the past five years .
You don't have any saved screeners yet
